Cytotoxic effects of tumour necrosis factor and gamma-interferon on acute myeloid leukaemia blasts.

por Price, G., Brenner, M. K., Prentice, H. G., Hoffbrand, A. V., Newland, A. C.
Publicado 1987

Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication.

por Foreman, N. K., Rill, D. R., Coustan-Smith, E., Douglass, E. C., Brenner, M. K.
Publicado 1993

Origin of marrow stromal cells and haemopoietic chimaerism following bone marrow transplantation determined by in situ hybridisation.

por Athanasou, N. A., Quinn, J., Brenner, M. K., Prentice, H. G., Graham, A., Taylor, S., Flannery, D., McGee, J. O.
Publicado 1990

Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma

por Cox, J E, Campos, S, Wu, J, May, R, Liu, H, Ramos, C A, Carrum, G, Heslop, H E, Brenner, M K, Kamble, R T
Publicado 2014

A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual dis...

por Gottlieb, D. J., Brenner, M. K., Heslop, H. E., Bianchi, A. C., Bello-Fernandez, C., Mehta, A. B., Newland, A. C., Galazka, A. R., Scott, E. M., Hoffbrand, A. V.
Publicado 1989